Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -71.10% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -18.42%. Over the past 30 days, the price of PALI has fallen by 73.72%. And in the last five days, it has surged by 30.93%.
The stock of Palisade Bio Inc (PALI) is currently priced at $1.24. In the last session, the stock climbed significantly, topping out at $16.0 after opening at $1.24. The day’s lowest price was $2.0 before the stock closed at $1.16.
Palisade Bio Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $4.65 on 07/29/24 and the lowest value was $0.60 on 04/04/25.
52-week price history of PALI Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Palisade Bio Inc’s current trading price is -73.33% away from its 52-week high, while its distance from the 52-week low is 106.67%. The stock’s price range during this period has varied between$0.60 and $4.65. The Palisade Bio Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.65 million for the day, a figure considerably higher than their average daily volume of 0.58 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Palisade Bio Inc (PALI) has experienced a quarterly rise of 72.22% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 5.94M and boasts a workforce of 8 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.7595, with a change in price of +0.4412. Similarly, Palisade Bio Inc recorded 522,333 in trading volume during the last 100 days, posting a change of +55.23%.
PALI’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for PALI stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
PALI Stock Stochastic Average
As of today, Palisade Bio Inc’s raw stochastic average for the last 50 days stands at 80.00%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 78.35%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 71.33% and 70.48%, respectively.
